GENE ONLINE|News &
Opinion
Blog

Atopic Dermatitis
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
Amgen, Kyowa Kirin Renew Long-Standing Partnership to Promote Atopic Dermatitis Therapy
2021-06-02
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Kymera Inks US$ 150M Deal with Sanofi for Potential Rheumatoid Arthritis and Eczema Treatments
2020-07-12
Torii Pharma’s Corectim Ointment Features in Japan’s NHI Drug Price List
2020-04-26
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top